Fluconazole treatment of fungal UTIs in pediatric patients

Durwood Earnest Neal, Gabriel Rodriguez, J. Alison Hanson, Edwin Harmon

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Fungal urinary tract infections (UTIs) are relatively uncommon but increasing in incidence. Despite the variety of agents available to treat these infections, they remain a therapeutic challenge to clinicians. Amphotericin B has traditionally been the drug of choice for systemic fungal infections, but its use is limited by frequent and severe adverse effects such as fever, chills, nausea, and phlebitis. Three pediatric patients with Candida infections were treated successfully with fluconazole (3 to 5mg/ kg per day). Although it is not currently indicated for children, fluconazole appears to be a safe and effective treatment for UTIs caused by Candida organisms in these patients.

Original languageEnglish (US)
Pages (from-to)169-170+177
JournalInfections in Medicine
Volume13
Issue number3
StatePublished - Dec 1 1996
Externally publishedYes

Fingerprint

Fluconazole
Candida
Urinary Tract Infections
Pediatrics
Phlebitis
Chills
Mycoses
Amphotericin B
Infection
Nausea
Fever
Incidence
Therapeutics
Pharmaceutical Preparations

Keywords

  • Amphotericin B
  • Candida
  • Fluconazole
  • Infections, fungal
  • Infections, urinary tract

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Neal, D. E., Rodriguez, G., Hanson, J. A., & Harmon, E. (1996). Fluconazole treatment of fungal UTIs in pediatric patients. Infections in Medicine, 13(3), 169-170+177.

Fluconazole treatment of fungal UTIs in pediatric patients. / Neal, Durwood Earnest; Rodriguez, Gabriel; Hanson, J. Alison; Harmon, Edwin.

In: Infections in Medicine, Vol. 13, No. 3, 01.12.1996, p. 169-170+177.

Research output: Contribution to journalArticle

Neal, DE, Rodriguez, G, Hanson, JA & Harmon, E 1996, 'Fluconazole treatment of fungal UTIs in pediatric patients', Infections in Medicine, vol. 13, no. 3, pp. 169-170+177.
Neal DE, Rodriguez G, Hanson JA, Harmon E. Fluconazole treatment of fungal UTIs in pediatric patients. Infections in Medicine. 1996 Dec 1;13(3):169-170+177.
Neal, Durwood Earnest ; Rodriguez, Gabriel ; Hanson, J. Alison ; Harmon, Edwin. / Fluconazole treatment of fungal UTIs in pediatric patients. In: Infections in Medicine. 1996 ; Vol. 13, No. 3. pp. 169-170+177.
@article{3e3e488c23624f0b962070ea102acb21,
title = "Fluconazole treatment of fungal UTIs in pediatric patients",
abstract = "Fungal urinary tract infections (UTIs) are relatively uncommon but increasing in incidence. Despite the variety of agents available to treat these infections, they remain a therapeutic challenge to clinicians. Amphotericin B has traditionally been the drug of choice for systemic fungal infections, but its use is limited by frequent and severe adverse effects such as fever, chills, nausea, and phlebitis. Three pediatric patients with Candida infections were treated successfully with fluconazole (3 to 5mg/ kg per day). Although it is not currently indicated for children, fluconazole appears to be a safe and effective treatment for UTIs caused by Candida organisms in these patients.",
keywords = "Amphotericin B, Candida, Fluconazole, Infections, fungal, Infections, urinary tract",
author = "Neal, {Durwood Earnest} and Gabriel Rodriguez and Hanson, {J. Alison} and Edwin Harmon",
year = "1996",
month = "12",
day = "1",
language = "English (US)",
volume = "13",
pages = "169--170+177",
journal = "Infections in Medicine",
issn = "0749-6524",
publisher = "CMP Healthcare Media LLC",
number = "3",

}

TY - JOUR

T1 - Fluconazole treatment of fungal UTIs in pediatric patients

AU - Neal, Durwood Earnest

AU - Rodriguez, Gabriel

AU - Hanson, J. Alison

AU - Harmon, Edwin

PY - 1996/12/1

Y1 - 1996/12/1

N2 - Fungal urinary tract infections (UTIs) are relatively uncommon but increasing in incidence. Despite the variety of agents available to treat these infections, they remain a therapeutic challenge to clinicians. Amphotericin B has traditionally been the drug of choice for systemic fungal infections, but its use is limited by frequent and severe adverse effects such as fever, chills, nausea, and phlebitis. Three pediatric patients with Candida infections were treated successfully with fluconazole (3 to 5mg/ kg per day). Although it is not currently indicated for children, fluconazole appears to be a safe and effective treatment for UTIs caused by Candida organisms in these patients.

AB - Fungal urinary tract infections (UTIs) are relatively uncommon but increasing in incidence. Despite the variety of agents available to treat these infections, they remain a therapeutic challenge to clinicians. Amphotericin B has traditionally been the drug of choice for systemic fungal infections, but its use is limited by frequent and severe adverse effects such as fever, chills, nausea, and phlebitis. Three pediatric patients with Candida infections were treated successfully with fluconazole (3 to 5mg/ kg per day). Although it is not currently indicated for children, fluconazole appears to be a safe and effective treatment for UTIs caused by Candida organisms in these patients.

KW - Amphotericin B

KW - Candida

KW - Fluconazole

KW - Infections, fungal

KW - Infections, urinary tract

UR - http://www.scopus.com/inward/record.url?scp=3643050356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3643050356&partnerID=8YFLogxK

M3 - Article

VL - 13

SP - 169-170+177

JO - Infections in Medicine

JF - Infections in Medicine

SN - 0749-6524

IS - 3

ER -